P&G v. Amway
This article was originally published in The Tan Sheet
Executive Summary
Houston federal judge Vanessa Gilmore rules P&G's Lanham Act claim that multi-level marketer disparaged Crest toothpaste is barred by Salt Lake City federal judge's earlier decision denying P&G's request to add product disparagement claims in a parallel lawsuit against Amway. In a Jan. 8 opinion, Gilmore also finds remaining P&G claims alleging Amway circulated false rumors that consumer products giant was associated with Satanism are similarly barred by res judicata effect of the Utah court's rulings, which were upheld by a Denver appeals court Jan. 6. P&G says it is "disappointed" in the rulings; Amway says court decisions end P&G's litigation against the company related to the Satanism rumors, with two cases still pending against Amway distributors...
You may also be interested in...
Roche/Genentech Keeps Commitment To External Cancer Innovation
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
Unprecedented To Lawful: Regulatory Precedent Needed For Cannabinoids’ Use In Supplements?
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: